CoChat

Effect of Low-Dose Perindopril/Indapamide on Albuminuria in Diabetes: Preterax in Albuminuria Regression: PREMIER

Open access
Mogensen, Carl Erik, Viberti, Giancarlo, Halimi, Serge, Ritz, Eberhard, Ruilope, Luis, Jermendy, György, Widimsky, Jiri, Sareli, Pinchas, Taton, Jan, Rull, Juan, Erdogan, Gürbüz, De Leeuw, Pieter W., Ribeiro, Arthur, Sanchez, Ramiro, Mechmeche, Rachid, Nolan, John, Sirotiakova, Jana, Hamani, Ahmed, Scheen, André, Hess, Bernhard, Luger, Anton, Thomas, Stephen M. · 2003 · Hypertension
Cited by 151

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Microalbuminuria in diabetes is a risk factor for early death and an indicator for aggressive blood pressure (BP) lowering. We compared a combination of 2 mg perindopril/0.625 mg indapamide with enalapril monotherapy on albumin excretion rate (AER) in patients with type 2 diabetes, albuminuria, and hypertension in a 12-month, randomized, double-blind, parallel-group international multicenter study. Four hundred eighty-one patients with type 2 diabetes and hypertension (systolic BP ≥140 mm Hg, <180 mm Hg, diastolic BP <110 mm Hg) were randomly assigned (age 59±9 years, 77% previously treated for hypertension). Results from 457 patients (intention-to-treat analysis) were available. After a 4-week placebo period, patients with albuminuria >20 and <500 μg/min were randomly assigned to a combination of 2 mg perindopril/0.625 mg indapamide or to 10 mg daily enalapril. After week 12, doses were adjusted on the basis of BP to a maximum of 8 mg perindopril/2.5 mg indapamide or 40 mg enalapril. The main outcome measures were overnight AER and supine BP. Both treatments reduced BP. Perindopril/indapamide treatment resulted in a statistically significant higher fall in both BP (−3.0 [95% CI −5.6, −0.4], P =0.012; systolic BP −1.5 [95% CI −3.0, −0.1] diastolic BP P =0.019) and AER −42% (95% CI −50%, −33%) versus −27% (95% CI −37%, −16%) with enalapril. The greater AER reduction remained significant after adjustment for mean BP. Adverse events were similar in the 2 groups. Thus, first-line treatment with low-dose combination perindopril/indapamide induces a greater decrease in albuminuria than enalapril, partially independent of BP reduction. A BP-independent effect of the combination may increase renal protection.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.hyp.0000064943.51878.58

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 151

Metadata

Authors
Mogensen, C. E., Viberti, G., Halimi, S., Ritz, E., Ruilope, L., Jermendy, G., Widimsky, J., Sareli, P., Taton, J., Rull, J., Erdogan, G., De Leeuw, P. W., Ribeiro, A., Sanchez, R., Mechmeche, R., Nolan, J., Sirotiakova, J., Hamani, A., Scheen, A., Hess, B., Luger, A., & Thomas, S. M.
Venue
Hypertension
Published
2003-05
Volume
41
Issue
5
Pages
1063-1071
ISSN
  • 0194-911X (ISSN-L)
  • 1524-4563
OpenAlex
W2105476950
Cited by
151
References
6
FWCI
9.67
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of Low-Dose Perindopril/Indapamide on Albuminuria in Diabetes: Preterax in Albuminuria Regression: PREMIER. https://app.cochat.ai/papers/10.1161/01.hyp.0000064943.51878.58
The paper
Mogensen, C. E., Viberti, G., Halimi, S., Ritz, E., Ruilope, L., Jermendy, G., Widimsky, J., Sareli, P., Taton, J., Rull, J., Erdogan, G., De Leeuw, P. W., Ribeiro, A., Sanchez, R., Mechmeche, R., Nolan, J., Sirotiakova, J., Hamani, A., Scheen, A., . . . Thomas, S. M. (2003). Effect of Low-Dose Perindopril/Indapamide on Albuminuria in Diabetes: Preterax in Albuminuria Regression: PREMIER. Hypertension. https://doi.org/10.1161/01.hyp.0000064943.51878.58

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.